Relapsed Gray Zone Lymphoma: A Rare Clinical Challenge

被引:0
|
作者
Chhabra, Pratyaksh [1 ]
Sahu, Prerna [1 ]
Deshmukh, Ishaan M. [1 ]
Sharma, Prakriti [1 ]
Madke, Bhushan [2 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Pathol, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Dermatol Venereol & Leprosy, Wardha, India
关键词
hodgkin lymphoma; chemotherapy-related toxicity; adjuvant radiation therapy; diffuse large b lymphoma; gray zone lymphoma; FEATURES INTERMEDIATE; HODGKIN;
D O I
10.7759/cureus.65592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gray zone lymphoma (GZL) is an extremely uncommon hematological cancer with characteristics in common with both classical Hodgkin's lymphoma (HL) and diffuse large B-cell lymphoma. In this case report, we present a rare case of a 22-year-old male who developed HL initially and then transitioned to relapsed or refractory GZL. The disease relapsed twice throughout, even after the peripheral blood stem cell transplant. The initial biopsy suggested it was classical HL, and the biopsy was done late in the progression of the disease; the features suggested it was GZL. The treatment consisted of curative and preventive chemotherapy, radiation therapy, and immunotherapy.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Gray Zone Lymphoma Current Diagnosis and Treatment Options
    Pilichowska, Monika
    Kritharis, Athena
    Evens, Andrew M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1251 - +
  • [32] Experience with Gray Zone Lymphoma (GZL) at Mayo Clinic: A Review of Clinical Characteristics and Treatment Outcomes
    Ghorab, Ahmad
    Mosalem, Osama
    Baidoun, Firas
    Tun, Han
    Moustafa, Muhamad Alhaj
    BLOOD, 2023, 142
  • [34] FFR gray zone and clinical outcome
    Adjedj, J.
    De Bruyne, B.
    Flore, V.
    Di Gioia, G.
    Ferrara, A.
    Pellicano, M.
    Bartunek, J.
    Vanderheyden, M.
    Wijns, W.
    Barbato, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 201 - 202
  • [35] FFR Gray zone and clinical outcome
    Adjedj, Julien
    De Bruyne, Bernard
    Flore, Vincent
    Di-Gioia, Giuseppe
    Ferrara, Angela
    Pellicano, Mariano
    Toth, Gabor G.
    Bartunek, Jozef
    Vanderheyden, Marc
    Wijns, William C.
    Barbato, Emanuele
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B15 - B15
  • [36] Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features
    Krijgsman, Oscar
    Gonzalez, Patricia
    Ponz, Olga Balague
    Roemer, Margaretha G. M.
    Slot, Stefanie
    Broeks, Annegien
    Braaf, Linde
    Kerkhoven, Ron M.
    Bot, Freek
    van Groningen, Krijn
    Beijert, Max
    Ylstra, Bauke
    de Jongi, Daphne
    HAEMATOLOGICA, 2013, 98 (12) : 1921 - 1929
  • [37] Internal Jugular Venous Thrombosis With Superior Vena Cava Syndrome: A Rare First Presentation of Gray Zone Lymphoma
    Weeraddana, Prabasha
    Nepal, Nisha
    Saleh, Mohammed
    Sandeep, Fnu
    Weerasooriya, Niwanthi
    Dandwani, Mehndi
    Ma, Eric
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023,
  • [38] Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma
    Dunleavy, Kieron
    ONCOLOGY-NEW YORK, 2017, 31 (06): : 499 - 501
  • [39] Systematic Literature Review of the Clinical Efficacy and Safety of Treatments in the Relapsed/Refractory Setting for Patients with Follicular Lymphoma or Marginal Zone Lymphoma
    Monga, Neerav
    Garside, Jamie
    O'Donovan, Peter
    Quigley, Joan
    Padhiar, Amie
    Parisi, Lori
    Tapprich, Christoph
    Nastoupil, Loretta
    BLOOD, 2017, 130
  • [40] Management of Relapsed Mantle Cell Lymphoma: Still a Treatment Challenge
    Ruan, Jia
    Coleman, Morton
    Leonard, John P.
    ONCOLOGY-NEW YORK, 2009, 23 (08): : 683 - 690